AU2002247725A1 - Antagonists fpr alpha4beta7-integrin - Google Patents
Antagonists fpr alpha4beta7-integrinInfo
- Publication number
- AU2002247725A1 AU2002247725A1 AU2002247725A AU2002247725A AU2002247725A1 AU 2002247725 A1 AU2002247725 A1 AU 2002247725A1 AU 2002247725 A AU2002247725 A AU 2002247725A AU 2002247725 A AU2002247725 A AU 2002247725A AU 2002247725 A1 AU2002247725 A1 AU 2002247725A1
- Authority
- AU
- Australia
- Prior art keywords
- fpr
- integrin
- antagonists
- antagonists fpr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000005557 antagonist Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10107707.6 | 2001-02-19 | ||
| DE2001107707 DE10107707A1 (de) | 2001-02-19 | 2001-02-19 | Antagonisten für alpha¶4¶beta¶7¶-Integrin |
| PCT/EP2002/001745 WO2002066500A2 (fr) | 2001-02-19 | 2002-02-19 | ANTAGONISTES DE Α4β7-INTEGRINE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002247725A1 true AU2002247725A1 (en) | 2002-09-04 |
Family
ID=7674566
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002247725A Abandoned AU2002247725A1 (en) | 2001-02-19 | 2002-02-19 | Antagonists fpr alpha4beta7-integrin |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2002247725A1 (fr) |
| DE (1) | DE10107707A1 (fr) |
| WO (1) | WO2002066500A2 (fr) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011095218A1 (fr) * | 2010-02-05 | 2011-08-11 | Polyphor Ag | Peptidomimétiques fixés au brin matrice ayant une activité modulatrice des cxcr7 |
| US9273093B2 (en) | 2012-10-11 | 2016-03-01 | Protagonist Therapeutics, Inc. | α4β7 peptide dimer antagonists |
| PL2968443T3 (pl) | 2013-03-15 | 2022-02-07 | Protagonist Therapeutics, Inc. | Analogi hepcydyny i ich zastosowania |
| US20140294902A1 (en) * | 2013-04-02 | 2014-10-02 | Protagonist Therapeutics, Inc. | Novel a4b7 peptide antagonists |
| CN113621027A (zh) | 2014-05-16 | 2021-11-09 | 领导医疗有限公司 | α4β7整联蛋白硫醚肽拮抗剂 |
| SG10201810154WA (en) | 2014-07-17 | 2018-12-28 | Protagonist Therapeutics Inc | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases |
| US10301371B2 (en) | 2014-10-01 | 2019-05-28 | Protagonist Therapeutics, Inc. | Cyclic monomer and dimer peptides having integrin antagonist activity |
| AU2015328002A1 (en) | 2014-10-01 | 2017-04-27 | Protagonist Therapeutics, Inc. | Novel alpha4beta7 peptide monomer and dimer antagonists |
| US10787490B2 (en) | 2015-07-15 | 2020-09-29 | Protaganist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| US11046695B2 (en) | 2015-11-11 | 2021-06-29 | Zealand Pharma A/S | Fragment synthesis of substituted cyclic peptides |
| CA3009834A1 (fr) | 2015-12-30 | 2017-07-06 | Protagonist Therapeutics, Inc. | Analogues de mimetiques d'hepcidine a demi-vie in vivo amelioree |
| EP3432906A4 (fr) | 2016-03-23 | 2020-04-01 | Protagonist Therapeutics, Inc. | Procédés de synthèse d'antagonistes de peptide alpha4beta7 |
| ES2884107T3 (es) | 2016-11-11 | 2021-12-10 | Zealand Pharma As | Multímeros de péptidos cíclicos con diana en la integrina alfa-4 beta-7 |
| WO2018205008A1 (fr) | 2017-05-10 | 2018-11-15 | Encycle Therapeutics, Inc. | PEPTIDES CYCLIQUES HOMODÉTIQUES CIBLANT L'INTÉGRINE α4β7 |
| TW201920234A (zh) | 2017-09-11 | 2019-06-01 | 美商領導醫療有限公司 | 類鴉片促效劑肽及其用途 |
| WO2019157268A1 (fr) | 2018-02-08 | 2019-08-15 | Protagonist Therapeutics, Inc. | Mimétiques d'hepcidine conjugués |
| JP7534382B2 (ja) | 2019-07-10 | 2024-08-14 | プロタゴニスト セラピューティクス， インコーポレイテッド | インターロイキン－２３受容体のペプチド阻害剤及び炎症性疾患を治療するためのその使用 |
| EP4090669A4 (fr) | 2020-01-15 | 2024-11-20 | Janssen Biotech, Inc. | Inhibiteurs peptidiques du récepteur de l'interleukine-23 et leur utilisation pour traiter des maladies inflammatoires |
| CN118063554A (zh) | 2020-01-15 | 2024-05-24 | 詹森生物科技公司 | 介白素-23受体的肽抑制剂及其治疗炎性疾病的用途 |
| EP4247403A4 (fr) | 2020-11-20 | 2024-12-11 | JANSSEN Pharmaceutica NV | Compositions d'inhibiteurs peptidiques du récepteur de l'interleukine-23 |
| AU2022311814A1 (en) | 2021-07-14 | 2024-02-29 | Janssen Biotech, Inc. | Lipidated peptide inhibitors of interleukin-23 receptor |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6037324A (en) * | 1996-01-04 | 2000-03-14 | Leukosite, Inc. | Inhibitors of MAdCAM-1-mediated interactions and methods of use therefor |
-
2001
- 2001-02-19 DE DE2001107707 patent/DE10107707A1/de not_active Withdrawn
-
2002
- 2002-02-19 WO PCT/EP2002/001745 patent/WO2002066500A2/fr not_active Ceased
- 2002-02-19 AU AU2002247725A patent/AU2002247725A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002066500A3 (fr) | 2003-01-30 |
| DE10107707A1 (de) | 2002-08-29 |
| WO2002066500A2 (fr) | 2002-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002341834A1 (en) | Antagonists | |
| AU2002313565A1 (en) | Putter-heads | |
| AU2002247725A1 (en) | Antagonists fpr alpha4beta7-integrin | |
| AU2002315122A1 (en) | Self-guyed structures | |
| AU2002251024A1 (en) | Substituted fluoroalcoxyphenylsulfonylurea | |
| AU2003236247A1 (en) | Bombesin antagonists | |
| AU2002321215A1 (en) | Substituted 4-aminocyclohexanols | |
| AU2002346030A1 (en) | Novel receptors | |
| AU2002313943A1 (en) | Electromobile | |
| WO2002077001A9 (fr) | Nouveaux recepteurs | |
| AU2002226571A1 (en) | Biligands | |
| AU2001100406A4 (en) | DriverSMS | |
| AU2002313073A1 (en) | Phytocystatin | |
| AU2002360933A1 (en) | Antagonists for alpha4-integrins | |
| AU2002257925A1 (en) | Numberplates | |
| AU2001100214A4 (en) | Dolly-trolley | |
| AU2001100532A4 (en) | FonePark | |
| AU2002100746A4 (en) | Adrail | |
| AU2001100338A4 (en) | Sunglove | |
| AU2001100522A4 (en) | e-Trans | |
| HK1063074A (en) | Opiate receptors | |
| AUPR910401A0 (en) | Athesive additives | |
| AU2002363642A1 (en) | Nk1 antagonists | |
| AU2002345578A1 (en) | Construction | |
| AU2002311774A1 (en) | Novel receptors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |